ALX Oncology Holdings (ALXO)
(Delayed Data from NSDQ)
$2.18 USD
+0.27 (14.14%)
Updated Oct 3, 2025 03:59 PM ET
After-Market: $2.17 -0.01 (-0.46%) 7:58 PM ET
3-Hold of 5 3
F Value B Growth D Momentum D VGM
Fundamental Charts
About Market Cap
As of the previous market close, ALX Oncology Holdings Inc. has a market cap of $102.28M, which represents its share price of $1.91 multiplied by its outstanding shares number of 53.55M. As a small-cap company, ALXO's shareholders are generally exposed to more risk than shareholders of mid and large-cap companies.
The company's Market Capitalization is a measurement of company size. It is calculation of the company's share price times the number of outstanding shares. Large market cap companies give stability and are good long-term investments. Small market cap companies can produce faster growth and bigger returns, but their stockholders are exposed to more risk.
ALXO 2.18 +0.27(14.14%)
Will ALXO be a Portfolio Killer in October?
Zacks Investment Research is releasing its prediction for ALXO based on the 1-3 month trading system that more than doubles the S&P 500.
Zacks News for ALXO
ALX Oncology Holdings (ALXO) Could Find a Support Soon, Here's Why You Should Buy the Stock Now
Is ALX Oncology Holdings (ALXO) Outperforming Other Medical Stocks This Year?
ALXO: What are Zacks experts saying now?
Zacks Private Portfolio Services
ALX Oncology Holdings (ALXO) Loses -27.11% in 4 Weeks, Here's Why a Trend Reversal May be Around the Corner
Other News for ALXO
ALXO makes New 52 Week Closing High on October 3
Is ALXO gaining bullish strength? New 52 Week Closing High shows up after rocketing 6.08%
The technical outlook for ALXO is unchanged after it falls 1.09% on October 1
ALXO forms 180 Bullish Setup on September 30
Is ALXO building bearish momentum? Bearish Engulfing shows up after tumbling 6.42%